Related Experiment Video

Updated: May 22, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

Pituitary adenoma pathogenesis: an update

Steve Rostad1

  • 1CellNetix Pathology and Laboratories, Seattle, Washington, USA.

Current Opinion in Endocrinology, Diabetes, and Obesity
|May 24, 2012
PubMed
Abstract

Insights

Recent research highlights molecular and genetic factors in pituitary adenoma development. Key findings include cell cycle dysregulation, oncogenes, tumor suppressor genes, microRNAs, and stem cells in tumorigenesis.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Pituitary adenomas are common neoplasms with diverse clinical presentations.
  • The pathogenesis of pituitary adenomas remains incompletely understood.
  • Understanding molecular mechanisms is crucial for diagnosis and treatment.

Purpose of the Study:

  • To review recent advancements in understanding pituitary adenoma tumorigenesis.
  • To elucidate the molecular and genetic mechanisms driving tumor development.
  • To highlight key pathways and cellular components involved.

Main Methods:

  • Literature review of recent studies on pituitary adenoma molecular genetics.
  • Analysis of data on cell cycle regulation, oncogenes, and tumor suppressor genes.
  • Investigation into the roles of microRNAs and stem cells in tumorigenesis.

Main Results:

  • Accumulating evidence points to molecular abnormalities in pituitary adenoma development.
  • Dysregulation of cell cycle, signal transduction, oncogenes, and tumor suppressor genes are implicated.
  • MicroRNAs and stem cells emerge as significant factors in tumorigenesis and potential therapeutic targets.

Conclusions:

  • Pituitary adenoma pathogenesis involves multiple steps and mechanisms.
  • Recent developments emphasize the role of cell cycle components, oncogenes, tumor suppressor genes, stem cells, and microRNAs.
  • Further research into these molecular aspects is essential for improved patient outcomes.

More Related Videos

Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome12:34

Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome

Published on: April 2, 2018

Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology09:48

Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology

Published on: February 25, 2022

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
The Pituitary Gland01:17

The Pituitary Gland

The pituitary is a small endocrine organ in the sphenoid bone under the hypothalamus. Primarily, the pituitary in adults has two distinct anatomical and functional regions— the anterior and posterior lobes. During human fetal development, a third pituitary gland region called the pars intermedia atrophies and disappears. However, some of its cells migrate and exist adjacent to the anterior pituitary in adults.
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...